Abstract
Background: Acute renal failure (ARF) resulting from ischemic or toxic insults remains a major health care problem because of its grave prognosis and the limited effectiveness of available treatment modalities. Current treatment options for ARF are limited to supportive measures and preventive strategies, none of which have been definitively shown to alter mortality.
Aim: To assess the ability of human umbilical cord blood CD34+ (HUCB CD34+) cells and mononuclear (HUCB MNC) cells to improve renal function of nephrotoxic kidney.
Methods: ARF was induced in 30 rats by glycerol. After 24 hours, ARF was confirmed by increased blood urea nitrogen (BUN), serum urea and creatinine levels. The rats were divided into 3 groups, group one included 10 rats treated with HUCB CD34+ cells, group two included 10 rats treated with HUCB MNC and group three included 10 rats treated with normal saline. Five rats were included in the study as a normal control group. Serial measurement of BUN, serum urea and creatinine levels were done every three days throughout the study. To proof homing of HUCB CD34+ into renal tissue, Y chromosome detection in renal tissue was carried out using Real time polymerase chain reaction (PCR) technique.
Results: Four days after the therapy, the renal function of CD34+ and MNC treated rats improved in comparison to saline treated rats. After 2 weeks of therapy and at the end of the study (28 days), ANOVA test revealed that, there was significant difference between the four studied groups (P=.000). Y chromosomes were detected in kidneys of CD34+ treated rats and MNC treated rats.
Conclusion: HUCB CD34+ cells and HUCB MNC improve renal function of nephrotoxic kidney with superiority to the HUCB MNC.
Keywords: Acute renal failure, hematopoietic stem cells (HSC), CD34+ progenitor cells, umbilical cord blood (UCB), hematological disorders, nephrotoxicity, immunomagnetic separation technique, blood urea nitrogen(BUN), creatinine levels, Y chromosome
Current Stem Cell Research & Therapy
Title: Effect of Human Umbilical Cord Blood Progenitor Cells Versus Mononuclear Cells on Acute Renal Failure Rat Model
Volume: 6 Issue: 4
Author(s): Magda I. Mohamed, Fadia M. Attia and Khaled A. Atwa
Affiliation:
Keywords: Acute renal failure, hematopoietic stem cells (HSC), CD34+ progenitor cells, umbilical cord blood (UCB), hematological disorders, nephrotoxicity, immunomagnetic separation technique, blood urea nitrogen(BUN), creatinine levels, Y chromosome
Abstract: Background: Acute renal failure (ARF) resulting from ischemic or toxic insults remains a major health care problem because of its grave prognosis and the limited effectiveness of available treatment modalities. Current treatment options for ARF are limited to supportive measures and preventive strategies, none of which have been definitively shown to alter mortality.
Aim: To assess the ability of human umbilical cord blood CD34+ (HUCB CD34+) cells and mononuclear (HUCB MNC) cells to improve renal function of nephrotoxic kidney.
Methods: ARF was induced in 30 rats by glycerol. After 24 hours, ARF was confirmed by increased blood urea nitrogen (BUN), serum urea and creatinine levels. The rats were divided into 3 groups, group one included 10 rats treated with HUCB CD34+ cells, group two included 10 rats treated with HUCB MNC and group three included 10 rats treated with normal saline. Five rats were included in the study as a normal control group. Serial measurement of BUN, serum urea and creatinine levels were done every three days throughout the study. To proof homing of HUCB CD34+ into renal tissue, Y chromosome detection in renal tissue was carried out using Real time polymerase chain reaction (PCR) technique.
Results: Four days after the therapy, the renal function of CD34+ and MNC treated rats improved in comparison to saline treated rats. After 2 weeks of therapy and at the end of the study (28 days), ANOVA test revealed that, there was significant difference between the four studied groups (P=.000). Y chromosomes were detected in kidneys of CD34+ treated rats and MNC treated rats.
Conclusion: HUCB CD34+ cells and HUCB MNC improve renal function of nephrotoxic kidney with superiority to the HUCB MNC.
Export Options
About this article
Cite this article as:
I. Mohamed Magda, M. Attia Fadia and A. Atwa Khaled, Effect of Human Umbilical Cord Blood Progenitor Cells Versus Mononuclear Cells on Acute Renal Failure Rat Model, Current Stem Cell Research & Therapy 2011; 6 (4) . https://dx.doi.org/10.2174/157488811797904344
DOI https://dx.doi.org/10.2174/157488811797904344 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Alert Cell Strategy: Mechanisms of Inflammatory Response and Organ Protection
Current Pharmaceutical Design Mesenchymal Stem Cell Therapy in Intracerebral Haemorrhagic Stroke
Current Medicinal Chemistry Air Pollution Exposure and Blood Pressure: An Updated Review of the Literature
Current Pharmaceutical Design Chalcones and Chromones in Copper-Catalyzed Azide–Alkyne Cycloadditions (CuAAC)
Current Organic Chemistry In Search of Novel and Therapeutically Significant Melatoninergic Ligands
Recent Patents on CNS Drug Discovery (Discontinued) Gold Nanoparticles - Synthesis and Applications in Cancer Management
Recent Patents on Materials Science Effectiveness of Resveratrol Against Cardiovascular Disease
Mini-Reviews in Organic Chemistry Oral and Topical Administration of ROQUETTE Schizochytrium sp. Alleviate Skin Inflammation and Improve Wound Healing in Mice
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry microRNAs in Cardiovascular Disease: Small Molecules but Big Roles
Current Topics in Medicinal Chemistry S-Nitrosylation: Targets, Controls and Outcomes
Current Genomics Tachykinins and the Cardiovascular System
Current Drug Targets Oxyprenylated Secondary Metabolites as Modulators of Lipid and Sugar Metabolism
Current Topics in Medicinal Chemistry Immunotherapy in Liver Diseases: A Balance Between Immunity and Tolerance
Current Drug Metabolism Small Molecule Antagonists of Integrin Receptors
Current Medicinal Chemistry The First Line of Defense Against Cardiac Hypertrophy
Current Molecular Medicine Nesfatin-1 and the Cardiovascular System: Central and Pheripheral Actions and Cardioprotection
Current Drug Targets Neopterin: From Forgotten Biomarker to Leading Actor in Cardiovascular Pathophysiology
Current Vascular Pharmacology Recent Development of Hydrogen Sulfide Therapeutics in the Treatment of Cardiovascular Diseases
Current Topics in Medicinal Chemistry Type 2 Transglutaminase in Neurodegenerative Diseases: The Mitochondrial Connection
Current Pharmaceutical Design Brutons Tyrosine Kinase as a New Therapeutic Target
Anti-Cancer Agents in Medicinal Chemistry